Literature DB >> 15944866

Is "cardiovascular protection" by estrogens due to inhibition of the sympathetic nervous system?

Murray Esler, Tye Dawood.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15944866     DOI： 10.1007/s10286-005-0279-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  18 in total

1.  Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2.

Authors:  A C Calkin; K Sudhir; S Honisett; M R I Williams; T Dawood; P A Komesaroff
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

2.  Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart.

Authors:  X J Du; A M Dart; R A Riemersma; M F Oliver
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

3.  Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure.

Authors:  G Grassi; M Colombo; G Seravalle; D Spaziani; G Mancia
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  Human muscle sympathetic nerve activity and plasma noradrenaline kinetics in space.

Authors:  Andrew C Ertl; André Diedrich; Italo Biaggioni; Benjamin D Levine; Rose Marie Robertson; James F Cox; Julie H Zuckerman; James A Pawelczyk; Chester A Ray; Jay C Buckey; Lynda D Lane; Richard Shiavi; F Andrew Gaffney; Fernando Costa; Carol Holt; C Gunnar Blomqvist; Dwain L Eckberg; Friedhelm J Baisch; David Robertson
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

5.  Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women.

Authors:  P A Komesaroff; M D Esler; K Sudhir
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

6.  Endogenous estrogens influence endothelial function in young men.

Authors:  Robert Lew; Paul Komesaroff; Maro Williams; Tye Dawood; Krishnankutty Sudhir
Journal:  Circ Res       Date:  2003-10-30       Impact factor: 17.367

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

9.  Sudden cardiac death triggered by an earthquake.

Authors:  J Leor; W K Poole; R A Kloner
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.